Derivation of human embryonic stem cell lines from single cells of 4-cell stage embryos: be aware of the risks Sir, Most of the human embryonic stem cell (hESC) lines have been derived from the inner mass of blastocyst stage embryos, some from 8-cell stage morula (Streclchenko et al., 2004) and some from isolated blastomeres from morulae (Chung et al., 2008) .
Sir, Most of the human embryonic stem cell (hESC) lines have been derived from the inner mass of blastocyst stage embryos, some from 8-cell stage morula (Streclchenko et al., 2004) and some from isolated blastomeres from morulae (Chung et al., 2008) .
In a very recent abstract, a Belgian team ( Van de Velde et al., 2008) elegantly established an embryonic stem cell line from a single blastomere isolated from a 4-cell stage embryo (from 1 out of 12 embryos). This team had a unique opportunity to establish good quality embryos from donated oocytes and sperm. By deriving a line from one blastomere, they gave evidence for the totipotency of single cells at 4-cell stage in human embryo. The resulting hESC line was, however, chromosomally abnormal with a deletion in chromosome 18 and a duplication in chromosome 7.
In Switzerland, the embryo research law is very strict, and obtaining good quality embryos for hESC derivation is virtually impossible, even though the law allows hESC derivation and culture. Our team recently derived a hESC line (Ch-ES1) from a frozen-thawed 4-cell stage embryo, in which only one blastomere survived thawing. The surviving cell grew on human foreskin feeders (Hovatta et al., 2003) and formed a hESC-like colony which has since then been passaged and cultured as a hESC line for over a year (Feki et al., 2008) . This line proved to be chromosomally very abnormal, with triploidies and several deletions and duplications. It forms malignant teratocarcinoma-like tumors when injected into SCID mice.
The Belgian team has now an excellent opportunity to show how often such lines are abnormal, a type of study still very difficult in many other countries. It is not new that poor quality embryos often have chromosomal abnormalities (Hardarson et al., 2003) , but on the other hand, we do not know yet how much culture conditions affect the chromosomes of early lines, even though culture adaptation is well known (Draper et al., 2004) .
In this light, the interpretation of many media that derivation of lines from single blastomeres is ethically a more acceptable method of derivation of hESC lines than destroying whole embryos cannot be supported by the scientific community. It appears that sometimes even the scientists themselves provoke such ideas (Chung et al., 2008) . The Belgian team has just been revealing very important biological mechanisms, but some media changed even their message to that direction. Also in Switzerland, we have to make clear that we now have an important tool to solve some problems in cancer development, but it does not offer solutions for any ethical questions in hECS derivation. The fact that hESC lines can be obtained from cells without destroying the embryo, or from cells of a 'dead' embryo, does not make such lines ethically more acceptable. Abnormality issues should not be underestimated.
Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model Sir, Fraser et al. (2007) identify the media they used in their work as mKSOM and KSOM, and characterize them as a 'synthetic oviductal medium enriched with potassium'. We wish to point out that his characterization is erroneous. A medium called SOM was developed by Lawitts and Biggers (1991) using the experimental strategy called 'sequential simplex optimization' (hence SOM). SOM medium was not designed to imitate the composition of oviductal secretions. It was developed to overcome the 2-cell block which, at the time, interfered with many studies on the developmental biology of the mouse embryo. KSOM was later modified by raising the potassium concentration in SOM (Lawitts and Biggers, 1993 ) based on measurements of the intracellular potassium concentration in blastomeres determined by the electron-probe analysis. Since the concentration of potassium in KSOM is considerably lower than the measured levels found in mouse oviductal fluid (Borland et al., 1977) , it is misleading to refer to KSOM as potassium-enriched SOM.
Fortuitously, KSOM was also found to be beneficial for the development of the mouse blastocyst (Erbach et al., 1994) and has been modified several times which we have called the KSOM family (see Biggers, 2002 for review) . One of these was produced by increasing the concentrations of glucose to 5.56 mmol/l and bovine serum albumin (BSA) to 4 mg/ml in order to support in vitro fertilization in the mouse (Summers et al., 1995) . This medium was denoted mKSOM. A second modification is KSOM AA , which is KSOM supplemented with 19 natural amino acids (Ho et al., 1995; Biggers et al., 2000) . A third modification, mKSOM AA , which contains high glucose, albumin and the 20 natural amino acids has also been used to support in vitro fertilization (Summers et al., 2000 (Summers et al., , 2005 .
We wish to stress that the abbreviations used by Fraser et al. (2007) are not the same as used by us. They have used mKSOM to mean our KSOM, and KSOM to mean KSOM AA . This type of confusion unfortunately arises frequently in the scientific and clinical literature due to the failure of authors to reference exactly the media they use. Since the constituents of media can have significant, sometimes unpredictable, effects, we urge authors and editors to ensure that the media used be uniquely identified and referenced.
